Recent insider selling at OptimizeRx, especially by Marion O...
Recent insider selling at OptimizeRx, especially by Marion Odence-Ford, may worry potential investors. The absence of insider buying and insignificant share ownership by insiders hint at possible doubts about future performance.
OptimizeRx's Stock Sinks To US$12.92, But Insiders Sold Even Lower
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3213Followers
0Following
7980Visitors
Follow